Home/Filings/4/0000899243-19-013104
4//SEC Filing

Cukier Herm 4

Accession 0000899243-19-013104

CIK 0001103021other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 6:00 PM ET

Size

11.6 KB

Accession

0000899243-19-013104

Insider Transaction Report

Form 4
Period: 2019-05-08
Cukier Herm
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2019-05-08$5.07/sh29,425$149,18537,421 total
  • Exercise/Conversion

    Common Stock

    2019-05-08+66,66666,666 total
  • Sale

    Common Stock

    2019-05-09$4.92/sh860$4,23136,381 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-05-08+66,666133,334 total
    Exp: 2021-05-08Common Stock (66,666 underlying)
Footnotes (3)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 66,666 Performance Restricted Stock Units ("PRSUs") granted to the Reporting Person on May 2, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended , subject to certain performance measures. The remainder of the PRSUs under this grant will vest: i) one-half after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures and ii) the remaining half after the first open window upon the filing of the Company's Annual Report in March 2021 subject to certain performance measures. The PRSUs convert into common stock on a one-for-one basis.
  • [F2]The shares of Common Stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of PRSUs.
  • [F3]On May 8, 2019, the Reporting Person sold an aggregate of 29,425 shares of the Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.19 per share and the lowest sale price was $4.99 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in these footnotes.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeother

Related Parties

1
  • filerCIK 0001739458

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:00 PM ET
Size
11.6 KB